Healthcare professionals should provide comprehensive patient education at treatment initiation, including written instructions and, where possible, practical demonstration
Efficacy and tolerability of tirzepatide, a dual glucosedependent insulinotropic peptide and glucagonlike peptide1 receptor agonist in patients with type 2 diabetes: a 12week, randomized, doubleblind, placebocontrolled study to evaluate different doseescalation regimens
1 (download XLSX Statistical source data
Dosage should be reviewed regularly, especially during the first few months of treatment or when side effects occur
Weekly GLP-1 injections include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and extended-release exenatide (Bydureon)